Shijiazhuang Pharmaceutical Group Co., Ltd. is a large pharmaceutical enterprise in China established by four pharmaceutical companies on August 21, 1997. It has total assets of 8 billion yuan, 18,000 employees, and 10 pharmaceutical companies. Five wholly-owned or holding subsidiaries, of which the holding subsidiary in Hong Kong, China Pharmaceutical Group Co., Ltd., is the first overseas listed company in the Chinese pharmaceutical industry and the largest pharmaceutical listed company in Hong Kong.

CSPC Pharmaceutical Group is one of the four important antibiotic and vitamin production bases in my country. It is also an important domestic chemical synthesis drug and comprehensive preparation production base. The products cover six series including antibiotics, vitamins, cardiovascular and cerebrovascular, antipyretic and analgesic, digestive system, and animal medicines. Beta-lactam antibiotics and vitamin C are the leading products. Among them, the annual production capacity of vitamin C is 30,000 tons, and the annual production capacity of 7-ACA is 1,600 tons, both ranking first in the world; the annual production capacity of antibiotic series APIs reaches 10,000 tons, ranking second in the country; the group's preparation varieties include water injection, Powder injections, tablets, hard capsules, soft capsules, granules, suppositories, pills and other dosage forms. The annual production capacity is 2.4 billion powder injections, 10 billion tablets, 5 billion capsules and 500 million soft capsules.

In September 2003, the trademarks "Shiyao", "Weihong" and "Ouyi" were recognized as "Famous Trademarks of Hebei Province" by the Hebei Provincial Administration for Industry and Commerce. In November 2004, "Shiyao" The trademark has been recognized as a "well-known trademark in China" by the State Administration for Industry and Commerce, which further enhances the brand connotation and establishes a good social image.